View ValuationGMR Solutions 향후 성장Future 기준 점검 4/6GMR Solutions (는) 각각 연간 79.9% 및 5.5% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 99.4% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 36.5% 로 예상됩니다.핵심 정보79.9%이익 성장률99.41%EPS 성장률Healthcare 이익 성장17.7%매출 성장률5.5%향후 자기자본이익률36.54%애널리스트 커버리지Good마지막 업데이트18 Aug 2026최근 향후 성장 업데이트공고 • Aug 13GMR Solutions Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026GMR Solutions Inc. reaffirmed earnings guidance for the year ending December 31, 2026. For the year, the company expects net revenue to be between $5,890 million and $6,180 million.공고 • Jun 02GMR Solutions Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2026GMR Solutions Inc. provided earnings guidance for the full year ending December 31, 2026. For the period, the company expects Net revenue of $5,890 million to $6,180 million.모든 업데이트 보기Recent updates공고 • Aug 13GMR Solutions Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026GMR Solutions Inc. reaffirmed earnings guidance for the year ending December 31, 2026. For the year, the company expects net revenue to be between $5,890 million and $6,180 million.Board Change • Aug 04High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Ellen Zane was the last director to join the board, commencing their role in 2026. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.공고 • Jul 24GMR Solutions Inc. to Report Q2, 2026 Results on Aug 13, 2026GMR Solutions Inc. announced that they will report Q2, 2026 results Pre-Market on Aug 13, 2026공고 • Jul 11GMR Solutions Inc.Appoints Jan Stern Reed to Chair of the Board's Nominating, Corporate Governance and Compliance Committee and A Member of the Board's Audit CommitteeGMR Solutions Inc. As of July 1, 2026, Ms. Jan Stern Reed 's preliminary committee assignments have been finalized. Ms. Reed is serving as the Chair of the Board's Nominating, Corporate Governance and Compliance Committee and a member of the Board's Audit Committee.내러티브 업데이트 • Jul 10GMRS: Higher Discount Rate Will Pressure Confidence In Air Operations DeliveryThe analyst price target for GMR Solutions has been reduced from $15 to $14, as analysts factor in a higher discount rate while still highlighting the company’s scale in U.S. emergency medical services and the potential benefits from higher margin air operations and contract stability. Analyst Commentary Recent Street research on GMR Solutions highlights a mix of optimism about the company’s position in U.S. emergency medical services and air operations, alongside a more cautious strand that focuses on execution risks, valuation, and the pace at which management can deliver on its plans.공고 • Jul 08GMR Solutions, Inc. Announces Board and Committee Appointments, Effective July 1, 2026GMR Solutions Inc. announced the appointments of Dr. Amar Desai and Ellen Zane to its Board of Directors, effective July 1, 2026. Dr. Desai is a respected healthcare executive, with a career spanning medicine, public health and executive leadership across integrated healthcare systems, physician organizations and Fortune 100 healthcare companies. Most recently he served as President of Optum Integrated Care, where he helped advance clinical quality, patient outcomes and value-based care strategies. Before that, Dr. Desai was Chief Executive Officer of Optum Health at UnitedHealth Group, overseeing one of the country's largest care delivery organizations serving more than 20 million patients. His leadership experience includes senior roles at CVS Health, DaVita, USC Care, and McKinsey & Company. Dr. Desai will serve on the Board's Nominating, Corporate Governance and Compliance Committee. Ellen Zane is CEO Emeritus of Tufts Medical Center and Founding Chair of Tufts Medicine. Zane currently serves on the boards of Boston Scientific, Haemonetics Corporation and Synchrony Financial, among other organizations, and serves as Adjunct Assistant Professor of Health Policy and Management at Harvard T.H. Chan School of Public Health. Zane will serve as Chair of the Board's Human Capital and Compensation Committee. The GMRS Board includes healthcare and investment leaders such as Timothy Wicks, former Chief Financial Officer of Optum and former Chief Executive Officer of OptumRx; Jan Stern Reed, former Senior Vice President, General Counsel and Corporate Secretary of Walgreens Boots Alliance Inc.; Johnny Kim, Managing Director on KKR's Health Care industry team; Max Lin, Partner and Head of KKR's Health Care industry team; and GMR Chief Executive Officer and Chairman, Nick Loporcaro. Together, these leaders bring experience that spans nearly every facet of the healthcare ecosystem—from care delivery and health system operations to governance, workforce leadership, finance and value-based care. Their combined expertise reflects GMR's vision for the future of emergency medical services—one in which EMS is increasingly recognized as an essential component of the broader healthcare system.새로운 내러티브 • Jul 08Rural Health Expansion And Higher Acuity Volumes Will Reshape Long Term Earnings PowerCatalysts About GMR Solutions GMR Solutions provides emergency medical services across ground and air, supporting 5.5 million patient encounters each year in markets covering more than 60% of the U.S. population. What are the underlying business or industry changes driving this perspective?Valuation Update With 7 Day Price Move • Jun 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to US$15.46, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 18x in the Healthcare industry in the US.새로운 내러티브 • Jun 24Rural Health Focus And Surprise Billing Clarity Will Support Future Earnings PotentialCatalysts About GMR Solutions GMR Solutions provides emergency medical services through a national network of ground and air transport, supported by technology enabled care coordination platforms. What are the underlying business or industry changes driving this perspective?Seeking Alpha • Jun 18GMR Solutions: The Post-IPO Discount Looks Too HarshSummary GMR Solutions Inc. is rated a buy, leveraging national scale in EMS and trading at a discounted ~7.5x NTM P/E. GMRS’s scale enables contract wins, new market growth, and competitive renewal advantages, driving incremental revenue and margin optimization. Strategic focus on higher-acuity, better-reimbursed services and programs like Nurse Navigation is improving revenue quality and unit economics. Downside risks include reimbursement volatility and 3.5x net leverage, but deleveraging and execution could close the valuation gap versus peers. Read the full article on Seeking AlphaValuation Update With 7 Day Price Move • Jun 10Investor sentiment improves as stock rises 21%After last week's 21% share price gain to US$13.18, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 16x in the Healthcare industry in the US.새로운 내러티브 • Jun 09Regulatory And Payer Risks Will Pressure Emergency Coverage Yet Rural Program Upside Will EmergeCatalysts About GMR Solutions GMR Solutions provides emergency medical services across ground and air transport, handling millions of patient encounters each year in the U.S. What are the underlying business or industry changes driving this perspective? Coverage of communities representing over 60% of the U.S. population and 5.5 million annual patient encounters gives GMR broad exposure to emergency care demand.공고 • Jun 02GMR Solutions Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2026GMR Solutions Inc. provided earnings guidance for the full year ending December 31, 2026. For the period, the company expects Net revenue of $5,890 million to $6,180 million.공고 • May 26GMR Solutions Inc. to Report Q1, 2026 Results on Jun 02, 2026GMR Solutions Inc. announced that they will report Q1, 2026 results on Jun 02, 2026실시간 뉴스 • May 18GMR Solutions Gains Ratings Upgrades After IPO and Debt ReductionGMR Solutions and its subsidiary Global Medical Response received upgraded credit ratings from Moody's Ratings and S&P Global Ratings following the company's IPO. Moody's raised GMR's corporate family rating to B1 from B2, while S&P assigned a B+ issuer credit rating and upgraded Global Medical Response to B+ from B. The agencies cited a strengthened financial profile, improved leverage position, greater financial flexibility, and lower annualized financing costs as key drivers for the upgrades. Stronger credit ratings typically give a company more options when it comes to refinancing, extending maturities, or pursuing future funding on potentially more favorable terms. For you, the key thing to watch now is how GMR Solutions uses this improved financial footing, including any changes to its capital structure, interest expenses, or appetite for acquisitions and growth investments.공고 • May 14GMR Solutions Inc. has completed an IPO in the amount of $478.723395 million.GMR Solutions Inc. has completed an IPO in the amount of $478.723395 million. Security Name: Class A Common Stock Security Type: Common Stock Securities Offered: 31,914,893 Price\Range: $15 Discount Per Security: $0.75 Transaction Features: Reserved Share Offering; Sponsor Backed OfferingBoard Change • May 13No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CEO & Chairman of the Board Nick Loporcaro was the last director to join the board, commencing their role in 2026. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.이익 및 매출 성장 예측NYSE:GMRS - 애널리스트 향후 추정치 및 과거 재무 데이터 (USD Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20286,741470705913612/31/20276,371411599696712/31/20266,03216148951976/30/20265,878-76355640N/A3/31/20265,83080310581N/A12/31/20255,74036383641N/A12/31/20245,976-70-22246N/A12/31/20235,395-20387258N/A애널리스트 향후 성장 전망수입 대 저축률: GMRS 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률(3.7%)보다 빠른 성장으로 간주됩니다.수익 vs 시장: GMRS (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.고성장 수익: GMRS 향후 3년 내에 수익을 낼 것으로 예상됩니다.수익 대 시장: GMRS 의 수익(연간 5.5%)이 US 시장(연간 13%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: GMRS 의 수익(연간 5.5%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: GMRS의 자본 수익률은 3년 후 36.5%로 높을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YHealthcare 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/08/18 01:25종가2026/08/18 00:00수익2026/06/30연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스GMR Solutions Inc.는 8명의 분석가가 다루고 있습니다. 이 중 7명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Andrew MokBarclaysJoanna Sylvia GajukBofA Global ResearchDaniel GrosslightCitigroup Inc5명의 분석가 더 보기
공고 • Aug 13GMR Solutions Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026GMR Solutions Inc. reaffirmed earnings guidance for the year ending December 31, 2026. For the year, the company expects net revenue to be between $5,890 million and $6,180 million.
공고 • Jun 02GMR Solutions Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2026GMR Solutions Inc. provided earnings guidance for the full year ending December 31, 2026. For the period, the company expects Net revenue of $5,890 million to $6,180 million.
공고 • Aug 13GMR Solutions Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026GMR Solutions Inc. reaffirmed earnings guidance for the year ending December 31, 2026. For the year, the company expects net revenue to be between $5,890 million and $6,180 million.
Board Change • Aug 04High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Ellen Zane was the last director to join the board, commencing their role in 2026. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
공고 • Jul 24GMR Solutions Inc. to Report Q2, 2026 Results on Aug 13, 2026GMR Solutions Inc. announced that they will report Q2, 2026 results Pre-Market on Aug 13, 2026
공고 • Jul 11GMR Solutions Inc.Appoints Jan Stern Reed to Chair of the Board's Nominating, Corporate Governance and Compliance Committee and A Member of the Board's Audit CommitteeGMR Solutions Inc. As of July 1, 2026, Ms. Jan Stern Reed 's preliminary committee assignments have been finalized. Ms. Reed is serving as the Chair of the Board's Nominating, Corporate Governance and Compliance Committee and a member of the Board's Audit Committee.
내러티브 업데이트 • Jul 10GMRS: Higher Discount Rate Will Pressure Confidence In Air Operations DeliveryThe analyst price target for GMR Solutions has been reduced from $15 to $14, as analysts factor in a higher discount rate while still highlighting the company’s scale in U.S. emergency medical services and the potential benefits from higher margin air operations and contract stability. Analyst Commentary Recent Street research on GMR Solutions highlights a mix of optimism about the company’s position in U.S. emergency medical services and air operations, alongside a more cautious strand that focuses on execution risks, valuation, and the pace at which management can deliver on its plans.
공고 • Jul 08GMR Solutions, Inc. Announces Board and Committee Appointments, Effective July 1, 2026GMR Solutions Inc. announced the appointments of Dr. Amar Desai and Ellen Zane to its Board of Directors, effective July 1, 2026. Dr. Desai is a respected healthcare executive, with a career spanning medicine, public health and executive leadership across integrated healthcare systems, physician organizations and Fortune 100 healthcare companies. Most recently he served as President of Optum Integrated Care, where he helped advance clinical quality, patient outcomes and value-based care strategies. Before that, Dr. Desai was Chief Executive Officer of Optum Health at UnitedHealth Group, overseeing one of the country's largest care delivery organizations serving more than 20 million patients. His leadership experience includes senior roles at CVS Health, DaVita, USC Care, and McKinsey & Company. Dr. Desai will serve on the Board's Nominating, Corporate Governance and Compliance Committee. Ellen Zane is CEO Emeritus of Tufts Medical Center and Founding Chair of Tufts Medicine. Zane currently serves on the boards of Boston Scientific, Haemonetics Corporation and Synchrony Financial, among other organizations, and serves as Adjunct Assistant Professor of Health Policy and Management at Harvard T.H. Chan School of Public Health. Zane will serve as Chair of the Board's Human Capital and Compensation Committee. The GMRS Board includes healthcare and investment leaders such as Timothy Wicks, former Chief Financial Officer of Optum and former Chief Executive Officer of OptumRx; Jan Stern Reed, former Senior Vice President, General Counsel and Corporate Secretary of Walgreens Boots Alliance Inc.; Johnny Kim, Managing Director on KKR's Health Care industry team; Max Lin, Partner and Head of KKR's Health Care industry team; and GMR Chief Executive Officer and Chairman, Nick Loporcaro. Together, these leaders bring experience that spans nearly every facet of the healthcare ecosystem—from care delivery and health system operations to governance, workforce leadership, finance and value-based care. Their combined expertise reflects GMR's vision for the future of emergency medical services—one in which EMS is increasingly recognized as an essential component of the broader healthcare system.
새로운 내러티브 • Jul 08Rural Health Expansion And Higher Acuity Volumes Will Reshape Long Term Earnings PowerCatalysts About GMR Solutions GMR Solutions provides emergency medical services across ground and air, supporting 5.5 million patient encounters each year in markets covering more than 60% of the U.S. population. What are the underlying business or industry changes driving this perspective?
Valuation Update With 7 Day Price Move • Jun 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to US$15.46, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 18x in the Healthcare industry in the US.
새로운 내러티브 • Jun 24Rural Health Focus And Surprise Billing Clarity Will Support Future Earnings PotentialCatalysts About GMR Solutions GMR Solutions provides emergency medical services through a national network of ground and air transport, supported by technology enabled care coordination platforms. What are the underlying business or industry changes driving this perspective?
Seeking Alpha • Jun 18GMR Solutions: The Post-IPO Discount Looks Too HarshSummary GMR Solutions Inc. is rated a buy, leveraging national scale in EMS and trading at a discounted ~7.5x NTM P/E. GMRS’s scale enables contract wins, new market growth, and competitive renewal advantages, driving incremental revenue and margin optimization. Strategic focus on higher-acuity, better-reimbursed services and programs like Nurse Navigation is improving revenue quality and unit economics. Downside risks include reimbursement volatility and 3.5x net leverage, but deleveraging and execution could close the valuation gap versus peers. Read the full article on Seeking Alpha
Valuation Update With 7 Day Price Move • Jun 10Investor sentiment improves as stock rises 21%After last week's 21% share price gain to US$13.18, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 16x in the Healthcare industry in the US.
새로운 내러티브 • Jun 09Regulatory And Payer Risks Will Pressure Emergency Coverage Yet Rural Program Upside Will EmergeCatalysts About GMR Solutions GMR Solutions provides emergency medical services across ground and air transport, handling millions of patient encounters each year in the U.S. What are the underlying business or industry changes driving this perspective? Coverage of communities representing over 60% of the U.S. population and 5.5 million annual patient encounters gives GMR broad exposure to emergency care demand.
공고 • Jun 02GMR Solutions Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2026GMR Solutions Inc. provided earnings guidance for the full year ending December 31, 2026. For the period, the company expects Net revenue of $5,890 million to $6,180 million.
공고 • May 26GMR Solutions Inc. to Report Q1, 2026 Results on Jun 02, 2026GMR Solutions Inc. announced that they will report Q1, 2026 results on Jun 02, 2026
실시간 뉴스 • May 18GMR Solutions Gains Ratings Upgrades After IPO and Debt ReductionGMR Solutions and its subsidiary Global Medical Response received upgraded credit ratings from Moody's Ratings and S&P Global Ratings following the company's IPO. Moody's raised GMR's corporate family rating to B1 from B2, while S&P assigned a B+ issuer credit rating and upgraded Global Medical Response to B+ from B. The agencies cited a strengthened financial profile, improved leverage position, greater financial flexibility, and lower annualized financing costs as key drivers for the upgrades. Stronger credit ratings typically give a company more options when it comes to refinancing, extending maturities, or pursuing future funding on potentially more favorable terms. For you, the key thing to watch now is how GMR Solutions uses this improved financial footing, including any changes to its capital structure, interest expenses, or appetite for acquisitions and growth investments.
공고 • May 14GMR Solutions Inc. has completed an IPO in the amount of $478.723395 million.GMR Solutions Inc. has completed an IPO in the amount of $478.723395 million. Security Name: Class A Common Stock Security Type: Common Stock Securities Offered: 31,914,893 Price\Range: $15 Discount Per Security: $0.75 Transaction Features: Reserved Share Offering; Sponsor Backed Offering
Board Change • May 13No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CEO & Chairman of the Board Nick Loporcaro was the last director to join the board, commencing their role in 2026. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.